Noribogaine
Noribogaine is a metabolite associated with ibogaine and is investigated in part because it may help isolate certain pharmacological effects. Human research questions still include cardiac effects, dosing, interactions, efficacy, and durability. Mechanistic plausibility cannot answer those questions on its own.
18-MC
18-MC has been studied as an ibogaine-related compound intended to separate possible anti-addiction effects from some of ibogaine’s unwanted effects. Its evidence base should be read by stage: preclinical findings do not establish a human benefit, and limited early clinical data do not establish safety or effectiveness.
Tabernanthalog & DLX‑007
Tabernanthalog and DLX‑007 are often discussed alongside research on non-hallucinogenic or modified psychedelic-like compounds. Their proposed mechanisms and development claims require close attention to public trial records, peer-reviewed results, and whether relevant human data have actually been released.